1. "Martin Tallman"
  2. "2012"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (11)
Groups
  1. Adult Leukemia (37)
  2. Center for Hematologic Malignancies (37)
  3. Department of Medicine (37)
  4. Hematologic Malignancies, Division of (37)
  5. GSK Faculty (5)
  6. Tow Center for Developmental Oncology (TCDO) (5)

More Groups

People
  1. Martin Tallman (37)
  2. Dan Douer (5)
  3. Eytan Stein (5)
  4. Omar Abdel-Wahab (4)
  5. Ross Levine (4)
  6. Jay Patel (3)

More People

Years
  1. 2012 (37)
Publications
  1. Blood (15)
  2. Journal of Clinical Oncology (4)
  3. Leukemia Research (2)
  4. Leukemia and Lymphoma (2)
  5. American Journal of Hematology (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. American Society of Clinical Oncology (4)
  3. Elsevier Ltd (2)
  4. Taylor & Francis Group (2)
  5. American Association for Cancer Research (1)
  6. Bentham Science Publishers (1)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes of patients older than 60 years with acute lymphoblastic leukemia: Survey from the Surveillance, Epidemiology, and End Results (SEER) program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Tallman, M. S.; Douer, D.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A comparison of CR versus CRi response following CPX-351 treatment of newly diagnosed AML in elderly patients (pts)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Practically all patients with acute myeloid leukemia (AML) in continuous complete remission for 3 years or more are cured of their disease: The ECOG experience
    Meeting Abstract

    Watts, J. M.; Zickl, L.; Litzow, M. R.; Luger, S. M.; Lazarus, H. M.; Cassileth, P. A.; Fernandez, H. F.; Douer, D.; Paietta, E.; Rowe, J. M.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Acute leukemias following a diagnosis of colorectal cancer: Are they therapy-related?
    Meeting Abstract

    Stein, E. M.; Pareek, V.; Kudlowitz, D.; Douer, D.; Tallman, M. S.
    Blood (2012)

    Fulltext@MSK | Save
  • Phase II trial of WT1 analog peptide vaccine in patients with acute myeloid leukemia (AML) in complete remission (CR)
    Meeting Abstract

    Rosenblat, T. L.; Frattini, M. G.; Chanel, S. M.; Dao, T.; Bernal, Y.; Jurcic, J. G.; Zhang, R.; Simancek, P.; Tallman, M. S.; Scheinberg, D. A.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Aberrant expression of the MLL5, BAALC, ID1, and WT1 genes is associated with higher induction mortality and poorer overall survival in acute promyelocytic leukemia patients treated with ATRA and anthracycline-based chemotherapy: An international consortium on acute promyelocytic leukemia study
    Meeting Abstract

    Lucena-Araujo, A. R.; Jacomo, R. H.; Kim, H. T.; Melo, R. A.; Bittencourt, R.; Pasquini, R.; Pagnano, K. B.; Fagundes, E.; Chauffaille, Mdlf; Chiattone, C. S.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Clonal chromosomal anomalies similar to CLL and other hematologic malignancies can be found in "normal" individuals
    Meeting Abstract

    Laurie, C. C.; Laurie, C. A.; Fridley, B.; Carlson, E.; Smoley, S. A.; Flinn, I. W.; Tallman, M. S.; Paietta, E.; Weinshilboum, R.; Kay, N. E.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • CPX-351 is effective in newly diagnosed older patients with AML and with multiple risk factors
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D. E.; Kolitz, J. E.; Tallman, M. S.; Hoering, A.; Chiarella, M. T.; Louie, A. C.; Feldman, E.
    Blood (2012)

    Fulltext@MSK | Save
  • Pharmacokinetics-based modification of intravenous pegylated asparaginase dosing in the context of a "pediatric-inspired" protocol in adults with newly diagnosed acute lymphoblastic leukemia (ALL)
    Meeting Abstract

    Douer, D.; Aldoss, I.; Lunning, M. A.; Ramezani, L.; Burke, P.; Mark, L.; Vrona, J.; Park, J. H.; Tallman, M. S.; Pullarkat, V.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
    Meeting Abstract

    DiNardo, C. D.; Levine, R. L.; Propert, K. J.; Loren, A. W.; Paietta, E.; Sun, Z. X.; Straley, K.; Yen, K.; Patel, J. P.; Agresta, S.; more...
    Blood (2012)

    Fulltext@MSK | Save